From the publishers of The New England Journal of Medicine

Save time and stay informed. Our physician-editors offer you clinical perspectives on key research and news.

  1. Home>
  2. Specialties>
  3. Dermatology>
  4. Summary and Comment

Melanoma Incidence and Mortality

Melanoma accounts for three-fourths of skin cancer deaths, and the lifetime risk for melanoma is estimated to be 1 in 75 by the year 2000. This epidemiological study calculated incidence and mortality rates of melanoma among Caucasians from 1973 to 1994 using data from the National Center for Health Statistics and the National Cancer Institute. The analysis included 116,055 melanoma deaths and excluded in situ lesions.

From 1973 to 1994, melanoma incidence and mortality increased 120% and 39%, respectively. In 1994, the mortality rate was twice as high among men than women. From 1973 to 1977, melanoma incidence increased 26% for men and 22% for women, but from 1990 to 1994, the incidence increased only 6.8% for men and actually decreased by 1.3% for women. Incidence rates stabilized or decreased from 1990 to 1994 among women younger than 60 years and men younger than 50 years, while the rates continued to rise for older men and women. The largest increases in incidence for men and women were for melanomas on the trunk.

Comment: While melanoma incidence and mortality are still increasing, the rate of increase is rapidly slowing, especially among women born since 1930 and men born since 1940. This slowdown among younger patients is probably due to reduced cumulative and intermittent exposure to intense ultraviolet light. The threefold greater increase in incidence over mortality suggests that melanoma lesions are now being diagnosed and treated at a thinner stage than in the past.

— GJ Hruza

Published in Journal Watch Dermatology February 1, 1999

Citation(s):

Hall HI et al. Update on the incidence and mortality from melanoma in the United States. J Am Acad Dermatol 1999 40 35-42.

Your Remark:

Reader Remarks are intended to encourage lively discussion of clinical topics with your peers in the medical community. Please consider this when composing your remark.

Fields marked with an * are required.

Name as you'd like it to appear:

Submitting a comment indicates you have read and agreed to the remark guidelines and declare:*

PRIVACY: We will not use your email address, submitted for a comment, for any other purpose nor sell, rent, or share your e-mail address with any third parties. Please see our Privacy Policy.

 

CLEAR erases anything you've added in any part of the form. CONTINUE allows you to check your entire post (and edit it if necessary) before submitting.

To ensure that your Reader Remark is not formatted as one long paragraph, precede new paragraphs with either a blank line or an indentation.

Search

Advanced

Article Tools

Reader Remarks

Sign-In

Forgot your password?

New to Journal Watch?

E-mail Alerts

Delivered to your inbox.
Tailored to your interests. Free.

Sign Up Now!

Journal Watch Newsletters

Available in 13 specialties with convenient delivery and 10 free online CME exams.

Subscribe Now!

Copyright © 1999. Massachusetts Medical Society. All rights reserved.